Project Cases

Our customers include medical device distributors, importers, and agents worldwide; hospital groups and orthopedic/spine departments; ambulatory surgical centers (ASCs); group purchasing organizations (GPOs); and OEM/ODM partners. We hold ~80% share of the Chinese kyphoplasty balloon catheter market, operate with contract manufacturing partners in Europe, and supply as a qualified vendor to member companies of Medtronic and Stryker.

Balloon kyphoplasty delivers rapid and sustained pain relief, with clinical studies reporting significant VAS score reduction within 24–48 hours post-procedure. The balloon inflation mechanism restores 30%–50% of lost vertebral body height on average and corrects local kyphotic deformity, improving spinal alignment. PMMA cement forms an internal cast that provides immediate mechanical stability, preventing further vertebral collapse. Patients typically ambulate within 24 hours and are discharged within 1–2 days, enabling faster return to daily activities compared with prolonged conservative therapy. Cement leakage rates are significantly lower than traditional vertebroplasty due to controlled low-pressure cavity filling. Long-term outcomes include improved quality of life, reduced need for opioid analgesia, and lower rates of fracture-related complications.